We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02849223
Recruitment Status : Recruiting
First Posted : July 29, 2016
Last Update Posted : September 7, 2017
Sponsor:
Collaborators:
Information provided by (Responsible Party):

July 24, 2016
July 29, 2016
September 7, 2017
July 2016
July 2018   (Final data collection date for primary outcome measure)
Wechsler Adult Intelligence Scale (WAIS)-III Working Memory Index [ Time Frame: Post-Intervention, 9-10 weeks after baseline assessment ]
Standard score
Same as current
Complete list of historical versions of study NCT02849223 on ClinicalTrials.gov Archive Site
University of California Performance Based Skills Assessment [ Time Frame: Post-Intervention, 9-10 weeks after baseline assessment ]
Total Score
Same as current
Resting state electroencephalogram (EEG) [ Time Frame: Post-Intervention, 8-9 weeks after baseline assessment ]
Theta amplified oscillatory power
Same as current
 
Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury
Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury
The primary aim of this study is to assess the magnitude of transcranial direct current stimulation (tDCS) -induced cognitive and functional change in patients with mild traumatic brain injury. This study will also attempt to identify biomarkers associated with treatment response. Last, acceptability and tolerability of procedures will be assessed. To accomplish these aims, a randomized, double-blind, sham-controlled, parallel groups, pilot study will be conducted in which participants are assigned to 24 sessions of tDCS or sham stimulation offered concurrent with working memory training. Neural efficiency will be measured with electroencephalogram (EEG) pre and post-intervention.
Transcranial direct current stimulation (tDCS) is a safe, non-invasive neuromodulation technique that shows promise as an intervention technique. The primary aim of this study is to assess the magnitude of tDCS-induced cognitive and functional change in patients with mild traumatic brain injury (TBI). In this double-blind, sham-controlled, pilot study, 24 veterans with mild TBI will be randomized to tDCS or sham conditions. Stimulation will be administered with a StarStim neurostimulator at 2 milliamps (mA) for 20 minutes. The anodal electrode will be placed over the left dorsal lateral prefrontal cortex. Twenty-four sessions of stimulation will be administered concurrent with 20 minutes of working memory training. Participants will continue with an additional 40 minutes of working memory training post-stimulation. Participant experience with neuromodulation will be assessed with a self-report questionnaire that lists common reactions to tDCS. Participant perception of the value of neuromodulation procedures will be assessed at weeks 4 and 8. A second aim is to identify biomarkers of treatment response. Resting state electroencephalogram (EEG) will be collected at three time points: prior to the first tDCS training session, immediately after the first training session, and post-intervention. This study will provide preliminary evidence of the efficacy of providing tDCS as an intervention to enhance cognitive and functional outcomes for individuals with mild traumatic brain injury. Furthermore, the results of this study will also increase the understanding of the mechanisms by which tDCS enhances cognitive performance. This knowledge has the potential to provide insight into the underlying therapeutic process as well as to guide development of the next generation of interventions. In addition, acceptability of the intervention will be monitored to identify potential barriers to administering tDCS in clinical practice.
Interventional
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Traumatic Brain Injury
  • Device: Anodal Transcranial Direct Current Stimulation
    2 milliamps (mA) of anodal stimulation will be applied to the left dorsal lateral cortex for 20 minutes concurrent with working memory training.
  • Device: Sham stimulation
    30 seconds of anodal TDCS stimulation will be applied to the left dorsal lateral cortex concurrent with working memory training
  • Experimental: Transcranial Direct Current Stimulation
    Participants will receive 24 sessions (3 times a week) of anodal transcranial direct current stimulation concurrent with working memory training. Stimulation will be administered at 2 milliamps (mA) for 20 minutes over the left dorsal lateral prefrontal cortex.
    Intervention: Device: Anodal Transcranial Direct Current Stimulation
  • Sham Comparator: Sham
    Participants will receive 24 sessions of working memory training. The experience of transcranial direct current stimulation will be simulated by administering 30 seconds of stimulation at the beginning of the session.
    Intervention: Device: Sham stimulation
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
32
July 2018
July 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Veterans enrolled at the Minneapolis Veterans Affairs (VA) Health Care System
  • Age of 18 and 60
  • Sustained a mild traumatic brain injury more than 1 year ago.

Exclusion Criteria:

  • Presence of a psychotic disorder
  • Severely depressed
  • Clinically unstable due to a hospitalization or medication change in the previous 4 weeks
  • Mild substance use disorder in the last month
  • Moderate to Severe substance use disorder in the last six months
  • Behavioral problems that prevent participation in a group intervention
  • Premorbid intellectual ability (IQ) below 70
  • Unable to provide informed consent
  • Have a guardian of person
  • Have another existing neurological condition that impacts cognitive functioning
  • Not fluent enough in English to understand testing procedures
  • Have a medical condition that is incompatible with transcranial direct current stimulation.
Sexes Eligible for Study: All
18 Years to 60 Years   (Adult)
No
Contact: Tasha M Nienow, PhD 612-467-1004 Tasha.Nienow@va.gov
Contact: Kelvin O Lim, MD 612-725-2000 Kelvin.Lim@va.gov
United States
 
 
NCT02849223
4654-A
No
Not Provided
Not Provided
Tasha Nienow, Minneapolis Veterans Affairs Medical Center
Minneapolis Veterans Affairs Medical Center
  • State of Minnesota
  • Minnesota Veterans Medical Research and Education Foundation
Principal Investigator: Tasha M Nienow, PhD Minneapolis Veteran Affairs Health Care System
Minneapolis Veterans Affairs Medical Center
September 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP